Chronic inflammasome activation is common in early onset AD patients [80] with NOD-, LRR-, and pyrin containing 3 (NLRP3) inflammasomes contributing to Aβ plaque and tau pathology in the context of Alzheimer’s Disease [80,81,112,113]. This evidence concerns the gene MAPT and Alzheimer disease.